Functional role and therapeutic targeting of microRNAs in inflammatory bowel disease
- 1 February 2018
- journal article
- review article
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 314 (2) , G256-G262
Abstract
Inflammatory bowel diseases (IBD) are chronic inflammatory gastrointestinal diseases, primarily consisting of ulcerative colitis and Crohn’s disease. The complex nature of the disease, as well as the limited therapeutic options characterized by low efficiency and major side effects, highlights the importance of developing novel strategies of therapeutic intervention in IBD. Susceptibility loci related to IBD are present only in a small percentage of IBD patients, implying that epigenetic modifications could influence the pathogenesis of the disease. MicroRNAs (miRNAs) are small noncoding RNAs that regulate multiple molecular pathways involved in IBD pathobiology. MiRNA inhibitors targeting the IBD-activated miRNAs could have therapeutic value for IBD patients. This review provides an overview of the recent advances in miRNA biology related to IBD pathogenesis and the pharmacological development of miRNA-based therapeutics.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (RO1 DK11003, RO1 DK60729)
- Broad Foundation
- Blinders Foundation for Crohn's Disease
This publication has 69 references indexed in Scilit:
- MicroRNA-21 Knockout Improve the Survival Rate in DSS Induced Fatal Colitis through Protecting against Inflammation and Tissue InjuryPLOS ONE, 2013
- miR-200b inhibits TGF-β1-induced epithelial-mesenchymal transition and promotes growth of intestinal epithelial cellsCell Death & Disease, 2013
- Improved Performance of Anti-miRNA Oligonucleotides Using a Novel Non-Nucleotide ModifierMolecular Therapy Nucleic Acids, 2013
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel diseaseNature, 2012
- Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohnʼs diseaseInflammatory Bowel Diseases, 2011
- Identification of microRNAs associated with ileal and colonic Crohnʼs disease†Inflammatory Bowel Diseases, 2010
- Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor modelNature Biotechnology, 2010
- MicroRNAs: Target Recognition and Regulatory FunctionsCell, 2009
- RNAi therapeutics: Principles, prospects and challengesAdvanced Drug Delivery Reviews, 2007
- Silencing of microRNAs in vivo with ‘antagomirs’Nature, 2005